GlassScriptPhysician profile
Michael J Anesta
NPI 1639158850
$1,943.95
in general payments reported to CMS, 2019-2025
18 companies · $93.01 in 2025
The $93.01 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $672 · 2020: $229 · 2021: $61.43 · 2022: $289 · 2023: $471 · 2024: $129 · 2025: $93.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $422.15 | 2019-2025 | |
| Amgen INC. | $253.75 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $161.31 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $153.10 | 2019-2022 | |
| Abiomed | $136.75 | 2023 | Impella |
| Atricure, INC. | $136.07 | 2023 | |
| Novartis Pharmaceuticals Corporation | $135.83 | 2019 | |
| Medtronic Vascular, INC. | $119.88 | 2020 | |
| Boston Scientific Corporation | $86.68 | 2022-2024 | Watchman Flx |
| Cvrx, INC. | $63.61 | 2023-2024 | Barostim Neo System |
| Novo Nordisk INC | $63.24 | 2023-2024 | Ozempic, Wegovy |
| Kowa Pharmaceuticals America, INC. | $58.99 | 2019-2020 | |
| Abbott Laboratories | $36.30 | 2019-2021 | |
| Philips North America LLC | $33.46 | 2022 | |
| Medtronic, INC. | $26.01 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.46 | 2022 | |
| Biotronik INC. | $18.81 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Anesta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.